Liver fibrosis with persistently normal alanine transaminase levels exhibits a distinct treatment response in MASLD.

BMJ Open Gastroenterol · 2025 · PMC12517019 · PMID 41067788

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, patients with normal ALT and liver fibrosis showed a trend towards higher AUCs for the relative change in LFC compared with those with elevated ALT and liver fibrosis (0.74 (95% CI: 0.64 to 0.85) vs 0.62 (95% CI: 0.54 to 0.70), p=0.062), with corresponding cut-off values of 39.85% and 20.57%, respectively ( figure 4D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.